In electrophysiological terms, experimental models of durable information storage in the brain include long-term potentiation (LTP), long-term depression, and kindling. Protein synthesis correlates with these enduring processes. We propose a fourth example of long-lasting information storage in the brain, which we call the GABA-withdrawal syndrome (GWS). In rats, withdrawal of a chronic intracortical infusion of GABA, a ubiquitous inhibitory neurotransmitter, induced epileptogenesis at the infusion site. This overt GWS lasted for days. Anisomycin, a protein synthesis inhibitor, prevented the appearance of GWS in vivo. Hippocampal and neocortical slices showed a similar post-GABA hyperexcitability in vitro and an enhanced susceptibility to LTP induction. One to four months after the epileptic behavior disappeared, systemic administration of a subconvulsant dose of pentylenetetrazol produced the reappearance of paroxysmal activity. The long-lasting effects of tonic GABAA receptor stimulation may be involved in long-term information storage processes at the cortical level, whereas the cessation of GABAA receptor stimulation may be involved
INTRODUCTION
Over the past few years, we have been involved in studies addressing GABA-mediated inhibition in several different models of epilepsy. In photo-sensitive baboons and in kindled rats, we have demonstrated that intracortically applied GABA has powerful anticonvulsant effects (Fukuda, 1987; Brailowsky, 1989) . In all cases, we observed that cessation of GABA infusion was associated with the appearance of epileptogenic activity at the site of the GABA infusion (Brailowsky, 1987) . Phenomenologically, we named this event the "GABA-withdrawal syndrome (GWS)".
Although originally described in the baboon, GWS was also induced in the rat somatomotor cortex (Bmilowsky, 1988) , hippocampus, and amygdala (Le Gal la Salle, 1988) . We also showed, using a 100 gg/laL/h dose, an inverse relation between GABA infusion time (from 6 h to 2 wk) and the latency and duration of epileptogenic activity .
With this procedure, a 3-h infusion of GABA was not effective in inducing GWS. We later found that hippocampal slices, perfused with GABA for 120 min, show an enhanced response to electrical stimulation and decreased paired-pulse during the washing period, GABA-mediated inhibition (GarciaUgalde, 1992 (Table 1) . It is noteworthy that acute microinjections of isoguvacine (2 min) were effective in inducing paroxysmal activity for 5 d or more (see Table and Fig. 1 ). Histological analysis showed an area of gliosis at the cortical infusion site and in the thalamic projection site, in particular on the upper portion of the ventrolateral (VL) and posterior groups, and in the reticular nucleus (Fig. 1) . GWS induction was not prevented by either APH or CNQX, which when given alone, had no effect.
Intracortical administration of glycine produced neither a behavioral nor an EEG abnormality in the 200-min follow-up period after drug infusion. Sixty to 120 days after the electrical signs of GWS disappeared, rats were injected systemically with a subconvulsant dose (20 to 25 mg/kg i.p.) of PTZ, a widely used epileptogenic agent (Dedeyn, 1992) , or with the PTZ vehicle (saline). In 12 of 14 rats, PTZ induced the reappearance of localized, highvoltage paroxysmal activity at the GABA-infused site, similar to the previous GWS and lasting from 60 to 90 min (Fig. 2) .
In search of a possible relation between the in vitro analog of GWS and in vitro long-term potentiation (LTP) (Bliss, Among the GABAA agonists, the quantitative differences in GWS may be related to their pharmacokinetic profiles: isoguvacine remains longer in the extracellular space because it is not taken up, whereas THIP is known for its short duration of action (Krogsgaard-Larsen, 1994 ). This distinction may explain why an acute microinjection of isoguvacine was as effective as a 30 min GABA infusion.
The specificity of the effects of GABA is supported by a) the lack of abnormalities observed after the cessation of glycine infusion; b) the effects of specific GABAA agonists (this study), and c) the potentiation of GWS produced by the neurosteroid allopregnanolone, an allosteric modulator of the GABAA receptor (Calixto, 1995) . The participation of GABAu receptors in the induction of GWS can be excluded because baclofen does not produce withdrawal signs (on the contrary, the drug itself induces paroxysmal activity). In addition, the specific GABA antagonists, phaclofen and CGP 35348, do not modify GWS features . In addition, GWS was not prevented by the glutamate receptor antagonists APH or CNQX.
In the current study, we also confirmed the histological changes previously reported by , both at the infusion site and in ipsilateral thalamic areas, adding immunohistochemical evidence (GFAP staining) of astrocytic participation in this reaction. The thalamic changes are similar to those reported with cortical epileptogenic foci that were induced with convulsant agents, such as bicuculline or penicillin, and shown to be excitotoxic in nature because they can be prevented by NMDA antagonists (Clifford, 1989 gamma-3, in chromosome 15ql 1-13, has been reported (Mclean, 1995) .
The GABAA receptor is a member of the superfamily of ionotropic receptors comprising several subunits, whose combination determines the particular pharmacology reported for diverse brain regions (Olsen, 1990; Macdonald, 1994) .
This property of allosteric modulation is relevant to widely used and clinically important drugs, such as the benzodiazepines, barbiturates, neurosteroids, and ethanol. After chronic administration, all these drugs, except the neurosteroids, can induce physical dependence and withdrawal signs. A common neurochemical mechanism involving GABA function has been suggested for such abstinence symptoms (Cowen, 1982) . The premenstrual syndrome has been proposed to be a possible withdrawal syndrome to progesterone, a positive modulator of the GABAg receptor (Gallo, 1993) . A progesterone metabolite, al|o-pregnano|one, significantly potentiates GWS (Calixto, 1995 (Barzilai, 1989; Oleary, 1995) . Anisomycin blocks GWS induction and, interestingly, also interferes with drug dependence (Williams, 1994) .
The GWS is a remarkable example of synaptic plasticity; its basic mechanism, neuronal and glial, may be analyzed from the rich perspectives offered by studies in epilepsy, drug dependence, and information storage.
